AUA: Increased mortality in Weekend ER Visits for Prostate Cancer Patients

This article originally appeared here.
Share this content:
AUA: Death Up in Weekend ER Visits for Prostate Cancer Patients
AUA: Death Up in Weekend ER Visits for Prostate Cancer Patients

(HealthDay News) -- For patients with metastatic prostate cancer, visiting the emergency department over the weekend is associated with increased odds of mortality, according to a study presented at the annual meeting of the American Urological Association, held from May 4 to 8 in San Diego.

Khurshid R. Ghani, M.D., from the Henry Ford Vattikuti Urology Institute in Detroit, and colleagues extracted data from the Nationwide Emergency Department Sample from Jan. 1, 2006, to Dec. 1, 2009, on emergency department visits for 15,365 patients with metastatic prostate cancer, including 3,943 weekend and 11,422 weekday visits.

The researchers found that 8.1 and 7.7 percent of patients died following a weekend and weekday visit, respectively. Compared with patients seen on weekdays, weekend patients were significantly older and healthier. Weekend patients were significantly more likely to visit a non-metropolitan hospital. Weekend emergency department patients were more likely to present with hematuria and less likely to present with acute renal failure. After adjustment for age and comorbidity, there was a significantly increased likelihood of mortality with weekend visits (odds ratio, 1.23).

"Our data clearly show [metastatic prostate cancer patients] have higher mortality rates after weekend visits to emergency departments," Ghani said in a statement. "But as to why, there is only a suggestion that they're more likely being treated at hospitals outside of metropolitan areas, places that may have limited access to advanced care."

More Information

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs